Spero Therapeutics, Inc.

Spero Therapeutics, Inc.verified

SPRO

Price:

$1.35

Market Cap:

$72.97M

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. t...[Read more]

Industry

Biotechnology

IPO Date

2017-11-02

Stock Exchange

NASDAQ

Ticker

SPRO

The Enterprise Value as of September 2024 (TTM) for Spero Therapeutics, Inc. (SPRO) is 14.38M

According to Spero Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.38M. This represents a change of 372.83% compared to the average of 3.04M of the last 4 quarters.

Spero Therapeutics, Inc. (SPRO) Historical Enterprise Value (quarterly & annually)

How has SPRO Enterprise Value performed in the past?

The mean historical Enterprise Value of Spero Therapeutics, Inc. over the last ten years is 112.13M. The current 14.38M Enterprise Value has changed 1.18% with respect to the historical average. Over the past ten years (40 quarters), SPRO's Enterprise Value was at its highest in in the September 2021 quarter at 485.93M. The Enterprise Value was at its lowest in in the September 2023 quarter at -24214561.20.

Quarterly (TTM)
Annual

Average

112.13M

Median

65.64M

Minimum

-56892336.25

Maximum

389.39M

Spero Therapeutics, Inc. (SPRO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Spero Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 136.98%

Maximum Annual Enterprise Value = 389.39M

Minimum Annual Increase = -213.08%

Minimum Annual Enterprise Value = -56892336.25

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20236.68M-117.85%
2022-37437820.25-109.61%
2021389.39M9.17%
2020356.70M136.98%
2019150.52M133.98%
201864.33M-213.08%
2017-56892336.25-186.67%
201665.64M-6.58%

Spero Therapeutics, Inc. (SPRO) Average Enterprise Value

How has SPRO Enterprise Value performed in the past?

The current Enterprise Value of Spero Therapeutics, Inc. (SPRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

119.55M

5-year avg

173.17M

10-year avg

112.13M

Spero Therapeutics, Inc. (SPRO) Enterprise Value vs. Peers

How is SPRO’s Enterprise Value compared to its peers?

Spero Therapeutics, Inc.’s Enterprise Value is less than Assembly Biosciences, Inc. (95.68M), greater than Achilles Therapeutics plc (-61656377.00), less than Instil Bio, Inc. (501.59M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (63.80M), less than NextCure, Inc. (21.40M), less than Nuvation Bio Inc. (1.01B),

CompanyEnterprise ValueMarket cap
95.68M$113.14M
-61656377.00$28.99M
501.59M$422.75M
-6333315.00$8.20M
63.80M$95.30M
21.40M$36.09M
1.01B$759.38M

Build a custom stock screener for Spero Therapeutics, Inc. (SPRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spero Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spero Therapeutics, Inc. (SPRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spero Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Spero Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Spero Therapeutics, Inc. (SPRO)?

What is the 3-year average Enterprise Value for Spero Therapeutics, Inc. (SPRO)?

What is the 5-year average Enterprise Value for Spero Therapeutics, Inc. (SPRO)?

How does the current Enterprise Value for Spero Therapeutics, Inc. (SPRO) compare to its historical average?